Clinical trial · Observational
Conditioning Regimen Before Infusion of Allogeneic Hematopoietic Stem Cells
Unrelated Donor Hematopoietic Stem Cell Transplantation After Nonmyeloablative Conditioning for Younger Patients With Hematologic Malignancies
NCT00770523CI-TRIAL-00004992completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Unrelated Donor Hematopoietic Stem Cell Transplantation After Nonmyeloablative Conditioning for Younger Patients with Hematologic Malignancies.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| HEMATOLOGIC MALIGNANCIES | Hematopoietic and Lymphoid Cell Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- treatment-related mortality and engraftment
- timeFrame
- all cause mortality
Secondary outcomes (1)
- measure
- regimen-related toxicities, graft-versus-host-disease, relapse, and overall survival.
- timeFrame
- Time point(s) at which outcome measure is assessed.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 15 Years
- Maximum age
- 55 Years
Show eligibility criteria text
Inclusion Criteria: -Patients should have an unrelated donor who is matched for HLA-A and -B by serology and for -DRB1 by molecular typing. Exclusion Criteria: * Patients should not have major illness or organ failure * Patients must not have a psychiatric disorder or mental deficiency severe as to make compliance with the treatment unlike, and making informed consent impossible. * Patients must not be pregnant or lactating.
References
Publications (0)
Data not yet available
No reference posted for this study.